@FiercePharma: DoJ adds weight to Abbott whistleblower suit. Report | Follow @FiercePharma
> Teva Pharmaceutical Industries posted record sales of its multiple sclerosis drug Copaxone and a one-third rise in adjusted quarterly earnings, but U.S. generics sales slipped and profits fell short of forecasts. Story | Report
> First year sales of Fanapt, a schizophrenia drug developed by Vanda Pharmaceuticals and sold by Novartis, totaled just $31.4 million, a fraction of the amount analysts expected. News
> Irish drugmaker Elan said its losses narrowed in the fourth quarter as it cut operating costs and revenues rose, driven by sales of multiple sclerosis drug Tysabri. Item
> Hungarian drugmaker Richter expects 2011 revenues to stay around 2010's $1.35 billion and predicts operating margins will fall to 16 percent from 23.3 percent because of higher marketing costs and an expansion of its sales network. Article
> Elliott Advisors stepped up pressure on Actelion, asking in a second letter within a week that the Swiss biotech rethink its stand-alone strategy. Report
Biotech News
@FierceBiotech: AZ's oral prostate cancer drug fails another Ph3 trial. News | Follow @FierceBiotech
@JohnCFierce: AZ and Wellpoint are teaming up on comparative effectiveness studies. If the government won't do it, private payers will. News | Follow @JohnCFierce
> Genzyme and Sanofi edge ever closer to the $20B "sweet spot." Article
> As early hype fades, pharma steadily backs away from RNAi. News
> Novartis balances the risks and rewards of pro bono R&D. Report
> Hedge fund pushes Actelion to open up on takeover talks. Story
Biotech Research News
> Stem cell skin gun developed for wound treatment. News
> Scientists find new pathway for antidepressants. Article
> Tufts launches website/HUB for pharma partnerships. Item
> Researchers discover key to macular degeneration. Article
> Researchers find genetic cause for sleepwalking. Story
> Light-up peptides could prevent nerve damage in surgery. News
Manufacturing News
> Bottle shortens home life of Pradaxa. Item
> UK defines supply chain roles during shortages. Report
> Weak pound drives exports, UK drug shortages. Story
> Consider leasing non-core equipment. Article
> Pharma fights retail Oxycontin thefts. Report
> Glass flakes prompt two American Regent recalls. News
And Finally... Atypical antipsychotics may lead to loss of brain tissue or exacerbate declines in brain volume caused by schizophrenia, a study in the Archives of General Psychiatry found. Report